The Oncogene Inhibitor Market Developments are primarily focused on preempting and overcoming mechanisms of drug resistance, which is the most significant clinical challenge to long-term success. A major development is the shift towards irrevocable inhibition, where next-generation molecules form covalent bonds with the target protein to ensure more potent and sustained suppression of...